These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles. Barthwal JP, Tandon SK, Agarwal VK, Dixit KS, Parmar SS. J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982 [No Abstract] [Full Text] [Related]
8. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. 3. Secondary action of the compounds 31037-S and 31087-S on the preincubated enzyme. Kurosawa A. Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):49-53. PubMed ID: 5771630 [No Abstract] [Full Text] [Related]
9. Inhibition of monoamine oxidation in rat liver mitochondria. Basu PS. Biochem Pharmacol; 1975 Dec 15; 24(24):2269-71. PubMed ID: 1218099 [No Abstract] [Full Text] [Related]
10. Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase. Yasuhara H. Jpn J Pharmacol; 1974 Aug 15; 24(4):523-33. PubMed ID: 4156374 [No Abstract] [Full Text] [Related]
11. [Comparative study in vitro and in vivo of the monoamine oxidase inhibitory properties of diacylhydrazines]. Cuparencu B, Barzu T, Cojocaru Z. J Physiol (Paris); 1969 Aug 15; 61 Suppl 1():112-3. PubMed ID: 5401989 [No Abstract] [Full Text] [Related]
12. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. II. Probable prosthetic groups of the enzyme, and their blocking by the compound 31037-S or 31087-S. Kurosawa A. Chem Pharm Bull (Tokyo); 1969 Jan 15; 17(1):43-8. PubMed ID: 5771629 [No Abstract] [Full Text] [Related]
13. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation. Mills J, Kattau R, Slater IH, Fuller RW. J Med Chem; 1968 Jan 15; 11(1):95-7. PubMed ID: 4384132 [No Abstract] [Full Text] [Related]
14. Structure-activity relationships of monoamine oxidase inhibitors. Fujita T. J Med Chem; 1973 Aug 15; 16(8):923-30. PubMed ID: 4745836 [No Abstract] [Full Text] [Related]
15. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns. Collins GG, Youdim MB, Sandler M. Biochem Pharmacol; 1972 Jul 15; 21(14):1995-8. PubMed ID: 4405452 [No Abstract] [Full Text] [Related]
16. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects]. LEVY J. Actual Pharmacol (Paris); 1961 Jul 15; 14():125-73. PubMed ID: 14464772 [No Abstract] [Full Text] [Related]
17. Correlation between monoamine oxidase inhibitors and anticonvulsants. Dwivedi C, Misra RS, Chaudhari A, Parmar SS. J Natl Med Assoc; 1980 Oct 15; 72(10):953-5. PubMed ID: 7420438 [Abstract] [Full Text] [Related]
18. Styrlquinazolones as monoamine oxidase inhibitors. Misra RS, Chaudhari A, Chaturvedi AK, Parmar SS, Rama Sastry BV. Pharmacol Res Commun; 1977 May 15; 9(5):437-46. PubMed ID: 882587 [No Abstract] [Full Text] [Related]